Optimizing Outcomes with Remote Monitoring: Expert Perspectives

Description

Learning Objectives
Upon completion of this activity, you should be able to: 

Explain the prevalence of heart failure and its impact on healthcare systems.
Identify appropriate candidates for remote hemodynamic monitoring based on clinical criteria and patient characteristics.
Describe the key specifications and functionalities of remote hemodynamic monitoring devices.
Discuss the overall impact of remote hemodynamic monitoring on heart failure patient care, including potential improvements and challenges.
Develop strategies for implementing remote hemodynamic monitoring in clinical practice including workflow integration, patient education, and follow-up care.

Faculty

Michael R. Zile, MD, FACC (Chair)

Medical University of South Carolina
Charleston, South Carolina

Disclosure

Consultant Fees/Honoraria: Abbott, Adona Medical, Alleviant, Aria CV, Avery Therapeutics, Inc., Boston Scientific, Cardiametrics, CVRx, Edwards, EBR, Edwards, Eli Lilly, GenKardia, Innoventric, Intershunt Technologies, Medtronic, Novartis, Preload Therapeutics, Pulnova, JNJ V wave, Vectorious, WhiteSwell, Zoll

JoAnn Lindenfeld, MD, FACC (Co-Chair)
Professor of Medicine
Vanderbilt University Medical Center
Disclosure
Consultant Fees/Honoraria: Abbott, Abiomed, Alleviant, AskBio, Boston Scientific, Cordio, CVRx, Edwards, Intershunt Technologies, Kestra, Merck, Merck & Co, Inc, Orchestra Biomed, Pulnova, Tenax, Vectorious, Volumetrix, VWAVE, WhiteSwell

William T. Abraham, MD, FACC
Director of Cardiovascular Medicine
The Ohio State University
Disclosure
Consultant Fee/Honoraria: AquaPass, Bioventrix, Cardiac Dimensions, Cordio Medical, CVRx, Innoventric, J&J V-Wave, Relief Cardiovascular, scPharmaceuticals, Sensible Medical, Vectorious Medical Technologies, WhiteSwell, Zoll Respicardia

Sandip Zalawadiya, MBBS
Associate Professor of Medicine
Vanderbilt University Medical Center
Disclosure
Consultant Fees/Honoraria: Abbott, Endotronix, Vectorious
Events Committee Member: CVRx

Lisa D. Rathman, MSN, CRNP

Nurse Practitioner and Cardiovascular Disease
PENN Medicine Lancaster General Health
Disclosure
Consultant Fees/Honoraria: Abbott, Bayer Healthcare Pharmaceuticals, Boston Scientific, CVRx, Impulse Dynamics, Medtronic, Merck, Novo Nordisk Inc.

Vishal N. Rao, MD, MPH
Advanced Heart Failure and Transplant Cardiologist
Medical University of South Carolina
Disclosure
None

Target Audience  
The target audience for this education includes cardiologists, nurse practitioners, heart failure specialists, electrophysiologists, interventional and invasive cardiologists, and CV care team members.

Important Dates 
Date of Release: June 29, 2026
Term of Approval/Date of Expiration: June 29, 2027

Acknowledgement
Educational support for this activity provided by Abbott.

Summary

Availability:

On-Demand

Access expires on Jun 29, 2027

Cost:

FREE

Credit Offered:

No Credit Offered